Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2019-01-29Clinical Trial Update: Early Feasibility Study to Assess Safety and Device Performance of AcoustiCare™ [NA]
The early feasibility study of the AcoustiCare device for heart failure has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-01-29Clinical Trial Update: A Comparison of Dilute Versus Concentrated Heparin for CRRT Anticoagulation [Phase 4]
A Phase 4 trial comparing dilute versus concentrated heparin for anticoagulation during continuous renal replacement therapy was terminated,…
-
CLINICAL_TRIALS withdrawal · 2019-01-25Clinical Trial Update: Comprehensive Medication Monitoring on Heart Failure Patient Outcomes [NA]
The clinical trial 'Comprehensive Medication Monitoring on Heart Failure Patient Outcomes' sponsored by Precera Bioscience, Inc. has been wi…
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study [Phase 2]
This update reports the results of the Phase 2 SUBQ-HF trial evaluating subcutaneous furosemide for acute decompensated heart failure; the s…
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patients With STEMI [Phase 3]
Phase 3 trial evaluating intracoronary injection of autologous bone marrow mononuclear cells for left ventricular contractility and remodeli…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2019-01-17Clinical Trial Update: Heart Failure After Heart Transplantation Due to Chronic Rejection [NA]
Clinical trial update on heart failure after heart transplantation due to chronic rejection, with current status listed as unknown.
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Promoting Patient-Centered Care Through a Heart Failure Simulation Study [NA]
A heart failure simulation study to promote patient-centered care has completed, and results were posted on 2019-01-16.
-
CLINICAL_TRIALS trial_result · 2019-01-11Clinical Trial Update: Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D [Phase 3]
Phase 3 trial update on the SonRtip lead with automatic AV-VV optimization in PARADYM RF SonR CRT-D for heart failure patients.
-
CLINICAL_TRIALS trial_result · 2019-01-11Clinical Trial Update: Pilot Study of Slow Release Oral Milrinone in Patients With Advanced Heart Failure [Phase 1, Phase 2]
Pilot study evaluating slow-release oral milrinone in patients with advanced heart failure completed Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2019-01-11Clinical Trial Update: MediGuide Registry
The MediGuide Registry trial sponsored by Abbott Medical Devices was terminated; results were posted on 2019-01-11.
-
CLINICAL_TRIALS trial_result · 2019-01-10Clinical Trial Update: Rivaroxaban Once Daily Versus Dose-adjusted Vitamin K Antagonist on the Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF) [Phase 4]
Phase 4 trial comparing rivaroxaban once daily to dose-adjusted vitamin K antagonist for biomarkers in patients with acute decompensated hea…
-
CLINICAL_TRIALS trial_result · 2019-01-02Clinical Trial Update: CRT Implant Strategy Using the Longest Electrical Delay for Non-left Bundle Branch Block Patients [NA]
A completed clinical trial evaluating CRT implant strategy based on the longest electrical delay in patients with non-left bundle branch blo…
-
CLINICAL_TRIALS trial_result · 2018-12-24Clinical Trial Update: Study to Demonstrate the Non-inferiority of Olmesartan Medoxomil Versus Candesartan Cilexetil in Reducing Blood B-type (or Brain) Natriuretic Peptide Levels at Week 24 [Phase 3]
A Phase 3 trial update comparing olmesartan medoxomil to candesartan cilexetil for reducing BNP levels in chronic heart failure was terminat…
-
CLINICAL_TRIALS trial_result · 2018-12-21Clinical Trial Update: Left Ventricular MultiSpot Pacing for CRT (iSPOT) [NA]
The iSPOT trial evaluating left ventricular MultiSpot pacing for cardiac resynchronization therapy in heart failure has completed and posted…
-
EMA withdrawal · 2018-12-20EMA Withdrawn: Ivabradine JensonR (ivabradine hydrochloride) — JensonR+ Limited
The EMA has withdrawn Ivabradine JensonR (ivabradine hydrochloride) from the market under the MAH JensonR+ Limited, effective as of 11/11/20…
-
FDA approval · 2018-12-19FDA Approved: METOPROLOL SUCCINATE — Original Application (Oryza Pharmaceuticals, Inc)
The FDA approved Oryza Pharmaceuticals' generic metoprolol succinate product, an extended-release beta-blocker used to treat hypertension, a…
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Optimised Pacing Program [Phase 3]
Phase 3 clinical trial update for an optimized pacing program addressing pacemaker-related complications and congestive heart failure.
-
CLINICAL_TRIALS trial_result · 2018-12-06Clinical Trial Update: Medical Arm of the Interagency Registry for Mechanically Assisted Circulatory Support
Clinical trial update for the Medical Arm of the Interagency Registry for Mechanically Assisted Circulatory Support completed with results p…
-
FDA approval · 2018-12-04FDA Approved: CANDESARTAN CILEXETIL — Original Application (Alembic Pharmaceuticals Limited)
FDA approved the original application for candesartan cilexetil from Alembic Pharmaceuticals Limited, enabling a generic version of the anti…
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Aldosterone Blockade in Heart Failure [Phase 3]
Phase 3 clinical trial update on aldosterone blockade for heart failure has completed.
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Use of Nesiritide in the Management of Acute Diastolic Heart Failure [Phase 4]
Phase 4 trial update on nesiritide for acute diastolic heart failure has been terminated.
-
CLINICAL_TRIALS withdrawal · 2018-11-02Clinical Trial Update: Study of High Dosage of Losartan in Comparison to Low Dose of Losartan in Heart Failure Patients [Phase 4]
A Phase 4 trial comparing high versus low doses of losartan in heart failure has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Differential Gene Expression in Patients With Heart Failure and Iron Deficiency - Effects of Ferric Carboxymaltose [Phase 4]
Phase 4 clinical trial exploring differential gene expression in heart failure patients with iron deficiency treated with ferric carboxymalt…
-
CLINICAL_TRIALS withdrawal · 2018-10-31Clinical Trial Update: Intravenous Vasodilator vs. Inotropic Therapy in Patients With Heart Failure [Phase 4]
APhase 4 trial comparing intravenous vasodilator versus inotropic therapy in acute heart failure has been withdrawn.
-
FDA approval · 2018-10-30FDA Approved: HYDRALAZINE — Supplemental Application (Nivagen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Hydralazine Hydrochloride (HYDRALAZINE HYDROCHLORIDE) from Nivagen Pharmaceuticals, Inc. under a…